1. MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells
   SANGMIN KIM et al, 2016 CrossRef
2. Challenges of Endocrine Therapy in Breast Cancer
   Sepideh Mansouri et al, 2017 CrossRef
3. PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
   Koichi Ito et al, 2017, npj Breast Cancer CrossRef
4. Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
   Daeun You et al, 2017, BMB Rep. CrossRef
5. Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
   T. A. Dronova et al, 2018, Usp. mol. onkol CrossRef
6. A Targeted Quantitative Proteomic Analysis Revealed Roles of Small GTPases in Acquired Tamoxifen Resistance in MCF-7 Cells
   Ming Huang et al, 2018, Anal. Chem. CrossRef
7. Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer
   Nataliya Babyshkina et al, 2019, Clin Exp Med CrossRef
8. Upregulation of SOX11 enhances tamoxifen resistance and promotes epithelial-to-mesenchymal transition via slug in MCF-7 breast cancer cells.
   Yingsheng Xiao et al, 2020, J Cell Physiol CrossRef
9. Expression of SATB1 and E-cad in tissues of patients with endometrial carcinoma and the relationship with clinicopathological features
   Yanli Feng et al, 2018, Exp Ther Med CrossRef
10. Bioinformatic analysis reveals the molecular targets of tangeretin in overcoming the resistance of breast cancer to tamoxifen
    Adam Hermawan et al, 2020, Gene Reports CrossRef
11. Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer.
    Jingwei Yao et al, 2020, Front Pharmacol CrossRef
12. Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells
    Sangmin Kim et al, 2021, European Journal of Pharmacology CrossRef
13. Tamoxifen: The Past, Present, and Future of a Previous Orphan Drug
    Ghadier Matariek et al, 2022, EJMED CrossRef
14. Lactate is a potential promoter of tamoxifen resistance in MCF7 cells
    Valentina Rossi et al, 2022, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
15. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis
    Zhihao Zhang et al, 2022, World J Surg Onc CrossRef
16. Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy
    Esteban Acosta-Ramos et al, 2024 CrossRef